5 Cheap Growth Stocks to Buy

2. Chimerix, Inc. (NASDAQ:CMRX)

Latest P/E Ratio: 0.65

Chimerix, Inc. (NASDAQ:CMRX) is a biotechnology company that is headquartered in Durham, North Carolina. The firm makes treatments for a variety of diseases such as tumors and liver malignancies.

Chimerix, Inc. (NASDAQ:CMRX)’s full year 2022 results saw it post a whopping 1,590% revenue growth which was fueled by the firm selling the rights to its TEMBEXA small pox drug to another company in September 2022. By the end of Q4 2022, 14 of the 943 hedge funds had bought the company’s shares.

Chimerix, Inc. (NASDAQ:CMRX)’s largest investor is David Rosen’s Rubric Capital Management which owns 7.5 million shares that are worth $13.9 million.

Follow Chimerix Inc (NASDAQ:CMRX)